Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection
- 21 September 2022
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 40 (43), 6288-6294
- https://doi.org/10.1016/j.vaccine.2022.09.029
Abstract
No abstract availableKeywords
Funding Information
- NSW Ministry of Health
- National Health and Medical Research Council (APP1116530)
This publication has 19 references indexed in Scilit:
- Protection against the Omicron Variant from Previous SARS-CoV-2 InfectionThe New England Journal of Medicine, 2022
- Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National SurveyOpen Forum Infectious Diseases, 2022
- Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsScience Immunology, 2022
- Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomesPublished by Cold Spring Harbor Laboratory ,2022
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South AfricaThe New England Journal of Medicine, 2021
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Nature, 2021
- Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort studyPublished by Cold Spring Harbor Laboratory ,2021
- High risk groups for severe COVID-19 in a whole of population cohort in AustraliaBMC Infectious Diseases, 2021
- Measuring the impact of the COVID-19 vaccine rolloutIndependent Nurse, 2021
- Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomesJournal of Clinical Epidemiology, 2010